Bridging the Regulatory Chasm in Investigator‐Initiated Human Subject Cannabis Research
Abstract
Despite widespread cannabis use and increasing public health concerns, federally compliant human pharmacology studies on cannabis remain exceedingly rare.This perspective details the complex and duplicative regulatory pathways that constrain rigorous investigation.Building on federal reports and calls to action, systemic reform is essential to support the rigorous human research needed to inform evidence-based cannabis policy.
Fields of Study & Subjects
Cannabis and Cannabinoid Research
Forensic Toxicology and Drug Analysis
Psychedelics and Drug Studies
Publication details
- Journal / source
- Clinical Pharmacology & Therapeutics
- Volume
- 119
- Issue
- 4
- Pages
- 834–837
- Publication date
- 7 January 2026
- Language
- EN